Direct Transcriptional Regulation of RelB by 1α,25-Dihydroxyvitamin D3 and Its Analogs

The nuclear factor-κB (NF-κB) protein RelB plays a unique role in dendritic cell (DC) function and, as such, is an important regulator of antigen presentation and immune regulation. In this study, inhibition of RelB expression in DCs exposed to an analog of the active form of vitamin D3 (1α,25-dihyd...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2003-12, Vol.278 (49), p.49378-49385
Hauptverfasser: Dong, Xiangyang, Craig, Theodore, Xing, Nianzeng, Bachman, Lori A., Paya, Carlos V., Weih, Falk, McKean, David J., Kumar, Rajiv, Griffin, Matthew D.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 49385
container_issue 49
container_start_page 49378
container_title The Journal of biological chemistry
container_volume 278
creator Dong, Xiangyang
Craig, Theodore
Xing, Nianzeng
Bachman, Lori A.
Paya, Carlos V.
Weih, Falk
McKean, David J.
Kumar, Rajiv
Griffin, Matthew D.
description The nuclear factor-κB (NF-κB) protein RelB plays a unique role in dendritic cell (DC) function and, as such, is an important regulator of antigen presentation and immune regulation. In this study, inhibition of RelB expression in DCs exposed to an analog of the active form of vitamin D3 (1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3)) was observed and shown to be mediated by the vitamin D receptor (VDR). Potential vitamin D response elements were identified within promoter regions of human and mouse relB genes. In gel shift experiments, these motifs specifically bound VDR·retinoid X receptor-α complexes. Reporter assays confirmed that transcriptional activity of human and mouse relB promoters was inhibited by 1α,25-(OH)2D3 agonists in a DC-derived cell line. The inhibition was abolished by mutagenesis of the putative vitamin D response elements and was enhanced by overexpression of VDR. Mutagenesis of NF-κB response elements within the relB promoter did not affect the magnitude of 1α,25-(OH)2D3 analog-mediated inhibition, ruling out an indirect effect on NF-κB signaling. Glucocorticoid caused additional inhibition of relB promoter activity when combined with the 1α,25-(OH)2D3 analog. This effect was dependent on the integrity of the NF-κB response elements, suggesting separate regulatory mechanisms for the two steroid pathways on this promoter. We conclude that relB is a direct target for 1α,25-(OH)2D3-mediated negative transcriptional regulation via binding of VDR·retinoid X receptor-α to discrete DNA motifs. This mechanism has important implications for the inhibitory effect of 1α,25-(OH)2D3 on DC maturation and for the potential immunotherapeutic use of 1α,25-(OH)2D3 analogs alone or combined with other agents.
doi_str_mv 10.1074/jbc.M308448200
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1074_jbc_M308448200</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820757157</els_id><sourcerecordid>S0021925820757157</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1730-a0ed56fc029d25c1d4d83860fb9d49d0d7b7e4b5536db141823267cada0029353</originalsourceid><addsrcrecordid>eNp1kE1OwzAQRi0EEqWwZe0DkDL-S5xlaSlUKkJCRbCzHNsprtKkskNFjsVFOBMpRWLFbEbf4n2aeQhdEhgRyPj1ujCjBwaSc0kBjtCAgGQJE-T1GA0AKElyKuQpOotxDf3wnAzQy9QHZ1q8DLqOJvht65taV_jJrd4rvQ-4KftU3eCiw-Tr84qKZOrfOhuaj27nW73xNZ4yrGuL523E455uVvEcnZS6iu7idw_R8-x2OblPFo9388l4kRiSMUg0OCvS0gDNLRWGWG4lkymURW55bsFmReZ4IQRLbUE4kZTRNDPa6v6hnAk2RKNDrwlNjMGVahv8RodOEVB7LarXov609IA8AK6_auddUNF4Vxtnf0Qo2_j_0G-rY2hv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Direct Transcriptional Regulation of RelB by 1α,25-Dihydroxyvitamin D3 and Its Analogs</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Dong, Xiangyang ; Craig, Theodore ; Xing, Nianzeng ; Bachman, Lori A. ; Paya, Carlos V. ; Weih, Falk ; McKean, David J. ; Kumar, Rajiv ; Griffin, Matthew D.</creator><creatorcontrib>Dong, Xiangyang ; Craig, Theodore ; Xing, Nianzeng ; Bachman, Lori A. ; Paya, Carlos V. ; Weih, Falk ; McKean, David J. ; Kumar, Rajiv ; Griffin, Matthew D.</creatorcontrib><description>The nuclear factor-κB (NF-κB) protein RelB plays a unique role in dendritic cell (DC) function and, as such, is an important regulator of antigen presentation and immune regulation. In this study, inhibition of RelB expression in DCs exposed to an analog of the active form of vitamin D3 (1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3)) was observed and shown to be mediated by the vitamin D receptor (VDR). Potential vitamin D response elements were identified within promoter regions of human and mouse relB genes. In gel shift experiments, these motifs specifically bound VDR·retinoid X receptor-α complexes. Reporter assays confirmed that transcriptional activity of human and mouse relB promoters was inhibited by 1α,25-(OH)2D3 agonists in a DC-derived cell line. The inhibition was abolished by mutagenesis of the putative vitamin D response elements and was enhanced by overexpression of VDR. Mutagenesis of NF-κB response elements within the relB promoter did not affect the magnitude of 1α,25-(OH)2D3 analog-mediated inhibition, ruling out an indirect effect on NF-κB signaling. Glucocorticoid caused additional inhibition of relB promoter activity when combined with the 1α,25-(OH)2D3 analog. This effect was dependent on the integrity of the NF-κB response elements, suggesting separate regulatory mechanisms for the two steroid pathways on this promoter. We conclude that relB is a direct target for 1α,25-(OH)2D3-mediated negative transcriptional regulation via binding of VDR·retinoid X receptor-α to discrete DNA motifs. This mechanism has important implications for the inhibitory effect of 1α,25-(OH)2D3 on DC maturation and for the potential immunotherapeutic use of 1α,25-(OH)2D3 analogs alone or combined with other agents.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M308448200</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>The Journal of biological chemistry, 2003-12, Vol.278 (49), p.49378-49385</ispartof><rights>2003 © 2003 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1730-a0ed56fc029d25c1d4d83860fb9d49d0d7b7e4b5536db141823267cada0029353</citedby><cites>FETCH-LOGICAL-c1730-a0ed56fc029d25c1d4d83860fb9d49d0d7b7e4b5536db141823267cada0029353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Dong, Xiangyang</creatorcontrib><creatorcontrib>Craig, Theodore</creatorcontrib><creatorcontrib>Xing, Nianzeng</creatorcontrib><creatorcontrib>Bachman, Lori A.</creatorcontrib><creatorcontrib>Paya, Carlos V.</creatorcontrib><creatorcontrib>Weih, Falk</creatorcontrib><creatorcontrib>McKean, David J.</creatorcontrib><creatorcontrib>Kumar, Rajiv</creatorcontrib><creatorcontrib>Griffin, Matthew D.</creatorcontrib><title>Direct Transcriptional Regulation of RelB by 1α,25-Dihydroxyvitamin D3 and Its Analogs</title><title>The Journal of biological chemistry</title><description>The nuclear factor-κB (NF-κB) protein RelB plays a unique role in dendritic cell (DC) function and, as such, is an important regulator of antigen presentation and immune regulation. In this study, inhibition of RelB expression in DCs exposed to an analog of the active form of vitamin D3 (1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3)) was observed and shown to be mediated by the vitamin D receptor (VDR). Potential vitamin D response elements were identified within promoter regions of human and mouse relB genes. In gel shift experiments, these motifs specifically bound VDR·retinoid X receptor-α complexes. Reporter assays confirmed that transcriptional activity of human and mouse relB promoters was inhibited by 1α,25-(OH)2D3 agonists in a DC-derived cell line. The inhibition was abolished by mutagenesis of the putative vitamin D response elements and was enhanced by overexpression of VDR. Mutagenesis of NF-κB response elements within the relB promoter did not affect the magnitude of 1α,25-(OH)2D3 analog-mediated inhibition, ruling out an indirect effect on NF-κB signaling. Glucocorticoid caused additional inhibition of relB promoter activity when combined with the 1α,25-(OH)2D3 analog. This effect was dependent on the integrity of the NF-κB response elements, suggesting separate regulatory mechanisms for the two steroid pathways on this promoter. We conclude that relB is a direct target for 1α,25-(OH)2D3-mediated negative transcriptional regulation via binding of VDR·retinoid X receptor-α to discrete DNA motifs. This mechanism has important implications for the inhibitory effect of 1α,25-(OH)2D3 on DC maturation and for the potential immunotherapeutic use of 1α,25-(OH)2D3 analogs alone or combined with other agents.</description><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNp1kE1OwzAQRi0EEqWwZe0DkDL-S5xlaSlUKkJCRbCzHNsprtKkskNFjsVFOBMpRWLFbEbf4n2aeQhdEhgRyPj1ujCjBwaSc0kBjtCAgGQJE-T1GA0AKElyKuQpOotxDf3wnAzQy9QHZ1q8DLqOJvht65taV_jJrd4rvQ-4KftU3eCiw-Tr84qKZOrfOhuaj27nW73xNZ4yrGuL523E455uVvEcnZS6iu7idw_R8-x2OblPFo9388l4kRiSMUg0OCvS0gDNLRWGWG4lkymURW55bsFmReZ4IQRLbUE4kZTRNDPa6v6hnAk2RKNDrwlNjMGVahv8RodOEVB7LarXov609IA8AK6_auddUNF4Vxtnf0Qo2_j_0G-rY2hv</recordid><startdate>20031205</startdate><enddate>20031205</enddate><creator>Dong, Xiangyang</creator><creator>Craig, Theodore</creator><creator>Xing, Nianzeng</creator><creator>Bachman, Lori A.</creator><creator>Paya, Carlos V.</creator><creator>Weih, Falk</creator><creator>McKean, David J.</creator><creator>Kumar, Rajiv</creator><creator>Griffin, Matthew D.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20031205</creationdate><title>Direct Transcriptional Regulation of RelB by 1α,25-Dihydroxyvitamin D3 and Its Analogs</title><author>Dong, Xiangyang ; Craig, Theodore ; Xing, Nianzeng ; Bachman, Lori A. ; Paya, Carlos V. ; Weih, Falk ; McKean, David J. ; Kumar, Rajiv ; Griffin, Matthew D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1730-a0ed56fc029d25c1d4d83860fb9d49d0d7b7e4b5536db141823267cada0029353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dong, Xiangyang</creatorcontrib><creatorcontrib>Craig, Theodore</creatorcontrib><creatorcontrib>Xing, Nianzeng</creatorcontrib><creatorcontrib>Bachman, Lori A.</creatorcontrib><creatorcontrib>Paya, Carlos V.</creatorcontrib><creatorcontrib>Weih, Falk</creatorcontrib><creatorcontrib>McKean, David J.</creatorcontrib><creatorcontrib>Kumar, Rajiv</creatorcontrib><creatorcontrib>Griffin, Matthew D.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dong, Xiangyang</au><au>Craig, Theodore</au><au>Xing, Nianzeng</au><au>Bachman, Lori A.</au><au>Paya, Carlos V.</au><au>Weih, Falk</au><au>McKean, David J.</au><au>Kumar, Rajiv</au><au>Griffin, Matthew D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct Transcriptional Regulation of RelB by 1α,25-Dihydroxyvitamin D3 and Its Analogs</atitle><jtitle>The Journal of biological chemistry</jtitle><date>2003-12-05</date><risdate>2003</risdate><volume>278</volume><issue>49</issue><spage>49378</spage><epage>49385</epage><pages>49378-49385</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>The nuclear factor-κB (NF-κB) protein RelB plays a unique role in dendritic cell (DC) function and, as such, is an important regulator of antigen presentation and immune regulation. In this study, inhibition of RelB expression in DCs exposed to an analog of the active form of vitamin D3 (1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3)) was observed and shown to be mediated by the vitamin D receptor (VDR). Potential vitamin D response elements were identified within promoter regions of human and mouse relB genes. In gel shift experiments, these motifs specifically bound VDR·retinoid X receptor-α complexes. Reporter assays confirmed that transcriptional activity of human and mouse relB promoters was inhibited by 1α,25-(OH)2D3 agonists in a DC-derived cell line. The inhibition was abolished by mutagenesis of the putative vitamin D response elements and was enhanced by overexpression of VDR. Mutagenesis of NF-κB response elements within the relB promoter did not affect the magnitude of 1α,25-(OH)2D3 analog-mediated inhibition, ruling out an indirect effect on NF-κB signaling. Glucocorticoid caused additional inhibition of relB promoter activity when combined with the 1α,25-(OH)2D3 analog. This effect was dependent on the integrity of the NF-κB response elements, suggesting separate regulatory mechanisms for the two steroid pathways on this promoter. We conclude that relB is a direct target for 1α,25-(OH)2D3-mediated negative transcriptional regulation via binding of VDR·retinoid X receptor-α to discrete DNA motifs. This mechanism has important implications for the inhibitory effect of 1α,25-(OH)2D3 on DC maturation and for the potential immunotherapeutic use of 1α,25-(OH)2D3 analogs alone or combined with other agents.</abstract><pub>Elsevier Inc</pub><doi>10.1074/jbc.M308448200</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2003-12, Vol.278 (49), p.49378-49385
issn 0021-9258
1083-351X
language eng
recordid cdi_crossref_primary_10_1074_jbc_M308448200
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Direct Transcriptional Regulation of RelB by 1α,25-Dihydroxyvitamin D3 and Its Analogs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A59%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20Transcriptional%20Regulation%20of%20RelB%20by%201%CE%B1,25-Dihydroxyvitamin%20D3%20and%20Its%20Analogs&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Dong,%20Xiangyang&rft.date=2003-12-05&rft.volume=278&rft.issue=49&rft.spage=49378&rft.epage=49385&rft.pages=49378-49385&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M308448200&rft_dat=%3Celsevier_cross%3ES0021925820757157%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0021925820757157&rfr_iscdi=true